Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Other Accumulated Expenses (2018 - 2019)

Historic Other Accumulated Expenses for Neurogene (NGNE) over the last 2 years, with Q4 2019 value amounting to $339000.0.

  • Neurogene's Other Accumulated Expenses rose 4125.0% to $339000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $339000.0, marking a year-over-year increase of 4125.0%. This contributed to the annual value of $339000.0 for FY2019, which is 4125.0% up from last year.
  • Per Neurogene's latest filing, its Other Accumulated Expenses stood at $339000.0 for Q4 2019, which was up 4125.0% from $240000.0 recorded in Q4 2018.
  • Neurogene's Other Accumulated Expenses' 5-year high stood at $339000.0 during Q4 2019, with a 5-year trough of $240000.0 in Q4 2018.